New pill aims to crush bad cholesterol in High-Risk patients
NCT ID NCT07218900
Summary
This study is testing whether a new oral drug called AZD0780, when taken alongside the common cholesterol medication rosuvastatin, can lower 'bad' LDL cholesterol more effectively than rosuvastatin alone. It will involve about 76 adult participants in Russia who have high cholesterol and are at risk for heart disease. For 12 weeks, half will take the new drug combination, while the other half takes a placebo with rosuvastatin, and neither they nor the doctors will know who gets which until the study ends.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAramil, 624002, Russia
-
Research Site
RECRUITINGIvanovo, 153012, Russia
-
Research Site
RECRUITINGMoscow, 105554, Russia
-
Research Site
RECRUITINGMoscow, 111539, Russia
-
Research Site
RECRUITINGMoscow, 117292, Russia
-
Research Site
RECRUITINGMoscow, 121552, Russia
-
Research Site
RECRUITINGPerm, 614000, Russia
-
Research Site
RECRUITINGSaint Petersburg, 194156, Russia
-
Research Site
SUSPENDEDSaratov, 410054, Russia
Conditions
Explore the condition pages connected to this study.